Accepted for/Published in: JMIR Research Protocols
Date Submitted: Apr 28, 2023
Date Accepted: Oct 29, 2023
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
A brief digital screening tool to address parental and adolescent tobacco and electronic cigarette use in pediatric medical care in Canada: a protocol for a pilot randomized-controlled trial
ABSTRACT
Background:
Though rates of tobacco smoking have decreased consistently over the past three decades; cigarette use remains the top preventable cause of premature death in North America. The Clinical Effort Against Secondhand Smoke Exposure (CEASE) is a medical clinic-based intervention that systematically screens parents for tobacco use and offers them direct access to evidence-based smoking cessation services. While the effectiveness of CEASE for parents who smoke has already been demonstrated in the U.S., the CEASE model has not yet been tested in Canada or among parents who use e-cigarettes, and among adolescents who use cigarettes and e-cigarettes.
Objective:
To demonstrate the feasibility and evaluate the implementation of the CEASE program for parental smoking cessation and its adapted version for adolescent smoking cessation and adolescent and parental vaping cessation.
Methods:
This is a single-blinded pilot randomized controlled study conducted in a tertiary care pediatric hospital in Montreal, Canada. Participants are parents or guardians of children 0-17 years as well as adolescent patients ages 14-17 years presenting to an outpatient pediatric clinic. The main outcome is feasibility of implementation of the CEASE model measured by recruitment and retention rates, for all 4 participant groups (parents and adolescents who use cigarettes and e-cigarettes). Secondary outcomes include use of cessation resources as well as changes in smoking and e-cigarette use, motivation to quit and quit attempts among participants. Participants complete electronic questionnaires on a tablet in clinic at baseline as well as electronic follow-up questionnaires at 1, 3 and 6 months. Individuals reporting successful quit attempts are invited to provide a urine sample for cotinine testing to biochemically confirm quit. Analyses include descriptive statistics as well exploratory trajectory analyses of smoking and e-cigarette use and motivation to quit.
Results:
Research activities began in June 2022. Participant enrolment and data collection began in February 2023 and are expected to be completed in 18 months.
Conclusions:
There is a strong need for effective and cost-effective smoking and vaping cessation interventions for parents and adolescents. If successful, this study will help inform the preparation of a fully powered RCT of CEASE in Canada in these populations. Clinical Trial: ClinicalTrials.gov ID: NCT 05366790
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.